TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.650
+0.185 (4.14%)
At close: Mar 9, 2026, 4:00 PM EDT
4.615
-0.035 (-0.75%)
After-hours: Mar 9, 2026, 4:00 PM EDT
TriSalus Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 45.15 | 29.43 | 18.51 | 12.4 | 8.4 | Upgrade
|
| Revenue Growth (YoY) | 53.41% | 58.99% | 49.31% | 47.58% | 54.60% | Upgrade
|
| Cost of Revenue | 6.97 | 4.1 | 2.61 | 2.26 | 1.19 | Upgrade
|
| Gross Profit | 38.19 | 25.33 | 15.91 | 10.14 | 7.21 | Upgrade
|
| Selling, General & Admin | 50.17 | 43.81 | 36.25 | 25.22 | 17.02 | Upgrade
|
| Research & Development | 14.97 | 17.69 | 29.84 | 21.36 | 14.22 | Upgrade
|
| Operating Expenses | 65.13 | 61.49 | 66.08 | 46.58 | 31.24 | Upgrade
|
| Operating Income | -26.95 | -36.17 | -50.18 | -36.44 | -24.03 | Upgrade
|
| Interest Expense | -5.54 | -3.09 | -0.02 | -0 | -1.76 | Upgrade
|
| Interest & Investment Income | 0.56 | 0.4 | 0.43 | 0.18 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -4.54 | -2.42 | -17.11 | -10.92 | -0.46 | Upgrade
|
| EBT Excluding Unusual Items | -36.48 | -41.27 | -66.87 | -47.18 | -26.25 | Upgrade
|
| Merger & Restructuring Charges | - | - | -4.3 | - | - | Upgrade
|
| Other Unusual Items | -2.74 | 11.23 | 11.81 | - | -2.59 | Upgrade
|
| Pretax Income | -39.22 | -30.04 | -59.35 | -47.18 | -28.84 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Net Income | -39.23 | -30.05 | -59.36 | -47.19 | -28.85 | Upgrade
|
| Preferred Dividends & Other Adjustments | 30.46 | 3.19 | 4.24 | 2.83 | - | Upgrade
|
| Net Income to Common | -69.69 | -33.23 | -63.6 | -50.02 | -28.85 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 25 | 9 | 0 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 25 | 9 | 0 | 9 | Upgrade
|
| Shares Change (YoY) | 49.61% | 169.61% | 2934.71% | -96.51% | 15.52% | Upgrade
|
| EPS (Basic) | -1.84 | -1.31 | -6.77 | -161.55 | -3.25 | Upgrade
|
| EPS (Diluted) | -1.84 | -1.31 | -6.77 | -161.55 | -3.25 | Upgrade
|
| Free Cash Flow | -18.93 | -41.19 | -51.17 | -32.97 | -23.79 | Upgrade
|
| Free Cash Flow Per Share | -0.50 | -1.63 | -5.45 | -106.48 | -2.68 | Upgrade
|
| Gross Margin | 84.57% | 86.06% | 85.93% | 81.79% | 85.80% | Upgrade
|
| Operating Margin | -59.68% | -122.88% | -271.06% | -293.91% | -286.06% | Upgrade
|
| Profit Margin | -154.35% | -112.92% | -343.59% | -403.42% | -343.35% | Upgrade
|
| Free Cash Flow Margin | -41.93% | -139.95% | -276.41% | -265.91% | -283.23% | Upgrade
|
| EBITDA | -26.32 | -35.42 | -49.49 | -36.04 | -23.57 | Upgrade
|
| EBITDA Margin | -58.29% | -120.35% | -267.36% | -290.70% | -280.54% | Upgrade
|
| D&A For EBITDA | 0.63 | 0.74 | 0.68 | 0.4 | 0.46 | Upgrade
|
| EBIT | -26.95 | -36.17 | -50.18 | -36.44 | -24.03 | Upgrade
|
| EBIT Margin | -59.68% | -122.88% | -271.06% | -293.91% | -286.06% | Upgrade
|
| Advertising Expenses | 1.4 | 0.5 | 1.3 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.